Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 16448

1.

Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.

Okada S, Morimoto T, Ogawa H, Sakuma M, Matsumoto C, Soejima H, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Saito Y; JPAD Trial Investigators.

Diabetes Care. 2018 Jun 16. pii: dc180368. doi: 10.2337/dc18-0368. [Epub ahead of print]

PMID:
29909377
2.

Social Network Characteristics Are Associated With Type 2 Diabetes Complications: The Maastricht Study.

Brinkhues S, Dukers-Muijrers NHTM, Hoebe CJPA, van der Kallen CJH, Koster A, Henry RMA, Stehouwer CDA, Savelkoul PHM, Schaper NC, Schram MT.

Diabetes Care. 2018 Jun 15. pii: dc172144. doi: 10.2337/dc17-2144. [Epub ahead of print]

PMID:
29907582
3.

Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride.

Kohler S, Kaspers S, Salsali A, Zeller C, Woerle HJ.

Diabetes Care. 2018 Jun 15. pii: dc171525. doi: 10.2337/dc17-1525. [Epub ahead of print]

PMID:
29907581
4.

Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125-1131.

Beran D, Hirsch IB, Yudkin JS.

Diabetes Care. 2018 Jun 15. pii: dcer09a. doi: 10.2337/dc18-er09a. [Epub ahead of print] No abstract available.

PMID:
29907580
5.

Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience.

Zinman B, Marso SP, Christiansen E, Calanna S, Rasmussen S, Buse JB; LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Diabetes Care. 2018 Jun 14. pii: dc172677. doi: 10.2337/dc17-2677. [Epub ahead of print]

PMID:
29903847
6.

Dietary Patterns Over Time and Microalbuminuria in Youth and Young Adults With Type 1 Diabetes: The SEARCH Nutrition Ancillary Study.

Costacou T, Crandell J, Kahkoska AR, Liese AD, Dabelea D, Lawrence JM, Pettitt DJ, Reynolds K, Mayer-Davis EJ, Mottl AK.

Diabetes Care. 2018 Jun 14. pii: dc180319. doi: 10.2337/dc18-0319. [Epub ahead of print]

PMID:
29903846
7.

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.

Schrieks IC, Nozza A, Stähli BE, Buse JB, Henry RR, Malmberg K, Neal B, Nicholls SJ, Rydén L, Mellbin L, Svensson A, Wedel H, Weichert A, Lincoff AM, Tardif JC, Grobbee DE, Schwartz GG.

Diabetes Care. 2018 Jun 14. pii: dc180158. doi: 10.2337/dc18-0158. [Epub ahead of print]

PMID:
29903845
8.

Diabetes and Prediabetes Prevalence by Race and Ethnicity Among People With Severe Mental Illness.

Mangurian CV, Schillinger D, Newcomer JW, Vittinghoff E, Essock SM, Zhu Z, Dyer WT, Schmittdiel JA.

Diabetes Care. 2018 Jun 13. pii: dc180425. doi: 10.2337/dc18-0425. [Epub ahead of print] No abstract available.

PMID:
29898903
9.

Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial.

Nauck MA, Jensen TJ, Rosenkilde C, Calanna S, Buse JB; LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Diabetes Care. 2018 Jun 13. pii: dc171825. doi: 10.2337/dc17-1825. [Epub ahead of print]

PMID:
29898902
10.

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors.

Klonoff DC, Parkes JL, Kovatchev BP, Kerr D, Bevier WC, Brazg RL, Christiansen M, Bailey TS, Nichols JH, Kohn MA.

Diabetes Care. 2018 Jun 13. pii: dc171960. doi: 10.2337/dc17-1960. [Epub ahead of print]

PMID:
29898901
11.

Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial).

Kuchay MS, Krishan S, Mishra SK, Farooqui KJ, Singh MK, Wasir JS, Bansal B, Kaur P, Jevalikar G, Gill HK, Choudhary NS, Mithal A.

Diabetes Care. 2018 Jun 12. pii: dc180165. doi: 10.2337/dc18-0165. [Epub ahead of print]

PMID:
29895557
12.

A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.

Ritzel R, Harris SB, Baron H, Florez H, Roussel R, Espinasse M, Muehlen-Bartmer I, Zhang N, Bertolini M, Brulle-Wohlhueter C, Munshi M, Bolli GB.

Diabetes Care. 2018 Jun 12. pii: dc180168. doi: 10.2337/dc18-0168. [Epub ahead of print]

PMID:
29895556
13.

Ambulatory Medication Reconciliation and Frequency of Hospitalizations and Emergency Department Visits in Patients With Diabetes.

Turchin A, Sosina O, Zhang H, Shubina M, Desai SP, Simonson DC, Testa MA.

Diabetes Care. 2018 Jun 11. pii: dc171260. doi: 10.2337/dc17-1260. [Epub ahead of print]

PMID:
29891639
14.

C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase.

Shields BM, McDonald TJ, Oram R, Hill A, Hudson M, Leete P, Pearson ER, Richardson SJ, Morgan NG, Hattersley AT; TIGI Consortium.

Diabetes Care. 2018 Jun 7. pii: dc180465. doi: 10.2337/dc18-0465. [Epub ahead of print]

PMID:
29880650
15.

Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications.

Musen G, Tinsley LJ, Marcinkowski KA, Pober D, Sun JK, Khatri M, Huynh R, Lu A, King GL, Keenan HA.

Diabetes Care. 2018 Jun 5. pii: dc171955. doi: 10.2337/dc17-1955. [Epub ahead of print]

PMID:
29871904
16.

Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.

Navarro-González JF, Sánchez-Niño MD, Donate-Correa J, Martín-Núñez E, Ferri C, Pérez-Delgado N, Górriz JL, Martínez-Castelao A, Ortiz A, Mora-Fernández C.

Diabetes Care. 2018 Jun 4. pii: dc180078. doi: 10.2337/dc18-0078. [Epub ahead of print]

PMID:
29866645
17.

Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study.

Warren B, Rebholz CM, Sang Y, Lee AK, Coresh J, Selvin E, Grams ME.

Diabetes Care. 2018 Jun 1. pii: dc180277. doi: 10.2337/dc18-0277. [Epub ahead of print]

PMID:
29858211
18.

Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study.

Hulman A, Witte DR, Vistisen D, Balkau B, Dekker JM, Herder C, Hatunic M, Konrad T, Færch K, Manco M.

Diabetes Care. 2018 May 31. pii: dc180279. doi: 10.2337/dc18-0279. [Epub ahead of print]

PMID:
29853473
19.

Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial.

Jarolim P, White WB, Cannon CP, Gao Q, Morrow DA.

Diabetes Care. 2018 May 30. pii: dc180109. doi: 10.2337/dc18-0109. [Epub ahead of print]

PMID:
29848776
20.

Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.

Luukkonen PK, Sädevirta S, Zhou Y, Kayser B, Ali A, Ahonen L, Lallukka S, Pelloux V, Gaggini M, Jian C, Hakkarainen A, Lundbom N, Gylling H, Salonen A, Orešič M, Hyötyläinen T, Orho-Melander M, Rissanen A, Gastaldelli A, Clément K, Hodson L, Yki-Järvinen H.

Diabetes Care. 2018 May 29. pii: dc180071. doi: 10.2337/dc18-0071. [Epub ahead of print]

PMID:
29844096

Supplemental Content

Loading ...
Support Center